Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04806386 · ClinicalTrials.gov registry record · NA
The Role of Fiber in the Prevention and Treatment of Fecal Incontinence
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT04806386: Completed NA study, sponsored by Massachusetts General Hospital.
NCT04806386 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04806386, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of fiber supplementation on the fecal metagenome and metabolome in relation to symptoms and anorectal physiology in post-menopausal women with irritable bowel syndrome with diarrhea suffering from liquid stool fecal incontinence (FI.)
Interventions
- DIETARY_SUPPLEMENT Psyllium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2021-07-21 |
| Est. Completion | 2024-12-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04806386
The ClinicalTrials.gov registry entry for NCT04806386 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Psyllium is the first listed.
NCT04806386 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04806386 about?
NCT04806386 is a clinical study titled "The Role of Fiber in the Prevention and Treatment of Fecal Incontinence". The purpose of this study is to determine the effect of fiber supplementation on the fecal metagenome and metabolome in relation to symptoms and anorectal physiology in post-menopausal women with irritable bowel syndrome with diarrhea suffering from liquid stool fecal incontinence (FI.)
What is the current status of trial NCT04806386?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2021-07-21. Estimated completion is 2024-12-11.
What interventions are being tested in trial NCT04806386?
The interventions under investigation include: Psyllium (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04806386?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.